IS5220A - Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum - Google Patents

Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Info

Publication number
IS5220A
IS5220A IS5220A IS5220A IS5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A IS 5220 A IS5220 A IS 5220A
Authority
IS
Iceland
Prior art keywords
carprofen
oxygenase
cyclo
dogs
inflammation
Prior art date
Application number
IS5220A
Other languages
English (en)
Icelandic (is)
Inventor
Marie Lundy Kristin
Paul Ricketts Anthony
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of IS5220A publication Critical patent/IS5220A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
IS5220A 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum IS5220A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05
PCT/IB1998/000662 WO1998050033A1 (en) 1997-05-05 1998-05-01 Cox-2 selective carprofen for treating pain and inflammation in dogs

Publications (1)

Publication Number Publication Date
IS5220A true IS5220A (is) 1999-10-19

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5220A IS5220A (is) 1997-05-05 1999-10-19 Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum

Country Status (32)

Country Link
EP (1) EP0988034A1 (es)
JP (1) JP2000513020A (es)
KR (2) KR20010012300A (es)
CN (1) CN1255059A (es)
AP (1) AP9801234A0 (es)
AR (2) AR011726A1 (es)
AU (1) AU6932198A (es)
BG (1) BG103852A (es)
BR (1) BR9808720A (es)
CA (1) CA2288759A1 (es)
DZ (1) DZ2479A1 (es)
EA (1) EA003696B1 (es)
GT (1) GT199800063A (es)
HR (1) HRP980244A2 (es)
HU (1) HUP0001286A3 (es)
ID (1) ID21311A (es)
IL (1) IL132570A0 (es)
IS (1) IS5220A (es)
MA (1) MA26491A1 (es)
NO (1) NO995389L (es)
NZ (1) NZ500183A (es)
OA (1) OA11213A (es)
PA (1) PA8450601A1 (es)
PE (1) PE72599A1 (es)
PL (1) PL337003A1 (es)
SK (1) SK148199A3 (es)
TN (1) TNSN98059A1 (es)
TW (1) TW590773B (es)
UY (1) UY24989A1 (es)
WO (1) WO1998050033A1 (es)
YU (1) YU55899A (es)
ZA (1) ZA983722B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
CA2347365A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
CA2363590A1 (en) * 1999-03-10 2000-09-14 G.D. Searle & Co. Method and composition for administering a cyclooxygenase-2 inhibitor
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001087343A2 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
AU6837701A (en) 2000-06-13 2001-12-24 American Home Prod Analgesic and anti-inflammatory compositions containing cox-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
ATE420201T1 (de) 2000-08-07 2009-01-15 Univ Vanderbilt Nachweis der cox-2 aktivität und von anandamid- metaboliten
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
DK1534305T3 (da) 2003-05-07 2007-02-05 Osteologix As Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte
EP1651210A1 (en) * 2003-07-31 2006-05-03 Pharmacia & Upjohn Company LLC Dispersible formulation of an anti-inflammatory agent
MX2007014422A (es) * 2005-05-20 2008-02-11 Pfizer Ltd Combinaciones sinergicas de farmacos atiinflamatorios con ligandos alfa-delta.
JP5553747B2 (ja) 2007-04-04 2014-07-16 シグモイド・ファーマ・リミテッド シクロスポリン医薬組成物
EP2061587A1 (en) 2007-04-26 2009-05-27 Sigmoid Pharma Limited Manufacture of multiple minicapsules
SI2432455T1 (sl) 2009-05-18 2015-04-30 Sigmoid Pharma Limited Sestava, obsegajoäśa oljne kapljice
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN112370450A (zh) * 2014-03-06 2021-02-19 阿莱塔纳治疗学股份有限公司 格拉匹纶组合物及其使用方法
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
EP3881829A1 (en) 2014-11-07 2021-09-22 Sublimity Therapeutics Limited Compositions comprising cyclosporin
WO2016112312A1 (en) * 2015-01-09 2016-07-14 Jaguar Animal Health Methods of treating diarrhea in companion animals
CN115335046A (zh) * 2020-03-25 2022-11-11 思研(Sri)国际顾问与咨询公司 脂肪氧合酶抑制剂
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
PA8450601A1 (es) 2000-05-24
HUP0001286A3 (en) 2000-12-28
IL132570A0 (en) 2001-03-19
UY24989A1 (es) 2001-10-25
NO995389L (no) 2000-01-04
NZ500183A (en) 2002-04-26
ID21311A (id) 1999-05-20
TNSN98059A1 (fr) 2005-03-15
YU55899A (sh) 2003-08-29
AR011726A1 (es) 2000-08-30
PL337003A1 (en) 2000-07-31
EA199900895A1 (ru) 2000-06-26
MA26491A1 (fr) 2004-12-20
WO1998050033A1 (en) 1998-11-12
HRP980244A2 (en) 1999-02-28
AR039628A2 (es) 2005-03-02
EP0988034A1 (en) 2000-03-29
ZA983722B (en) 1999-11-04
CN1255059A (zh) 2000-05-31
AP9801234A0 (en) 1999-11-04
EA003696B1 (ru) 2003-08-28
CA2288759A1 (en) 1998-11-12
DZ2479A1 (fr) 2003-02-01
NO995389D0 (no) 1999-11-04
JP2000513020A (ja) 2000-10-03
AU6932198A (en) 1998-11-27
OA11213A (en) 2003-07-14
KR20040004406A (ko) 2004-01-13
BR9808720A (pt) 2000-07-11
GT199800063A (es) 1999-10-26
KR20010012300A (ko) 2001-02-15
TW590773B (en) 2004-06-11
BG103852A (en) 2000-06-30
HUP0001286A2 (hu) 2000-11-28
PE72599A1 (es) 1999-08-12
SK148199A3 (en) 2001-09-11

Similar Documents

Publication Publication Date Title
IS5220A (is) Sýkló-oxýgenasa-2 valvíst karprófen til meðhöndlunar á sársauka og bólgu hjá hundum
NO20005190L (no) Terapeutiske angiogene faktorer og fremgangsmåter til anvendelse derav
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
IS5405A (is) Prostaglandín gerandefni og notkun þeirra til að meðhöndla beintruflanir
DE69825447D1 (de) Gerät zur dermatologischen behandlung
IS2107B (is) Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
NO983576D0 (no) Brönnbehandlingsfluider og fremgangsmåter
NO20022656L (no) Caspaseinhibitorer og anvendelse derav
IS5921A (is) Staðgengnar Bensópýrahliðstæður til notkunar við meðhöndlun á bólgu
DE69911221D1 (de) Methode und gerät zur darreichung von therapeutischen mitteln in verbindung mit dem plazieren von radioaktiven körnern
IS5928A (is) Aðferðir og samsetningar til að hindra lyfjaþol
DE60019490D1 (de) Brennstofförder-und behandlungsvorrichtung
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
ID18741A (id) Zat nikotinat dalam terapi
DE69701250D1 (de) Tierbehandlungsvorrichtung
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
NO20012738D0 (no) Terapeutiske produkter og anvendelse derav
IS5809A (is) Samtíma inngjöf ACAT og MMP tálma til meðhöndlunar á skemmdum vegna fituhrörnunar
ITMI20001555A0 (it) Procedimento e dispositivo di trattamento elettrochimico
DK0915655T3 (da) Fremgangsmåde og sammensætning til behandling mod parasitter i dyrs omgivelser
DE69932577D1 (de) Stangenbehandlungsgerät und Stangenladegerät
IS6428A (is) Aðferð og blanda til að meðhöndla sársauka
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
IS5857A (is) Aðferð til flökunar á fiski og flökunarvél til notkunar við flökunina